Sign In
Buy BHVN
$13.50
-0.320 (-2.32%)
At Close: Jul 31, 2026
How Much Upside is Left in Biohaven Ltd. (BHVN)? Wall Street Analysts Think 127.52%
10:56am, Thursday, 04'th Dec 2025
The average of price targets set by Wall Street analysts indicates a potential upside of 127.5% in Biohaven Ltd. (BHVN). While the effectiveness of this highly sought-after metric is questionable, the
Pre-Market Stock Futures: The futures are trading higher on Wednesday after a stellar day across Wall Street on Tuesday. All of the major indices finished the day higher, with the technology-heavy NAS
AXQ Capital LP Boosts Stake in Biohaven Ltd. $BHVN
03:36am, Tuesday, 25'th Nov 2025
AXQ Capital LP grew its stake in shares of Biohaven Ltd. (NYSE: BHVN) by 59.8% in the undefined quarter, according to its most recent Form 13F filing with the SEC. The institutional investor owned 17,
Biohaven Insiders Bet $33 Million on a Turnaround
12:37pm, Thursday, 20'th Nov 2025
When corporate executives make multi-million-dollar personal investments in the company they lead, it is one of the most potent signals an investor can receive. At Biohaven NYSE: BHVN, that signal ha
Biohaven's Chief Accounting Officer Scooped Up 17,000 Shares. Is the Stock a Buy?
05:15pm, Wednesday, 19'th Nov 2025
On November 17, 2025, Biohaven's Chief Accounting Officer, George Clark, acquired 17,000 shares of company stock. Mr. Clark's purchase was valued at approximately $144,800.
NEW HAVEN, Conn. , Nov. 13, 2025 /PRNewswire/ -- Biohaven Ltd.
Biohaven Q3 Earnings: Falling Back To Earth With A Thud
03:54pm, Wednesday, 12'th Nov 2025
Biohaven (BHVN) narrows focus to three late-stage clinical programs and implements cost-cutting to address heavy R&D spending and steep share price declines. BHVN's pipeline includes Opakalim for depr
FLEX LNG, Biohaven And Other Big Stocks Moving Lower In Wednesday's Pre-Market Session
08:10am, Wednesday, 12'th Nov 2025
U.S. stock futures were higher this morning, with the Nasdaq futures gaining around 100 points on Wednesday.
Biohaven Announces Pricing of $175 Million Public Offering of Common Shares
07:15am, Wednesday, 12'th Nov 2025
NEW HAVEN, Conn. , Nov. 12, 2025 /PRNewswire/ -- Biohaven Ltd.
Biohaven Announces Proposed Public Offering of Common Shares
04:05pm, Tuesday, 11'th Nov 2025
NEW HAVEN, Conn. , Nov. 11, 2025 /PRNewswire/ -- Biohaven Ltd.
Biohaven Reports Third Quarter 2025 Financial Results and Recent Business Developments
06:58am, Monday, 10'th Nov 2025
NEW HAVEN, Conn. , Nov. 10, 2025 /PRNewswire/ -- Biohaven Ltd.
Biohaven Stock Hits 52-Week Low, Cuts R&D Spending After FDA Rejection
12:53pm, Wednesday, 05'th Nov 2025
Biohaven Ltd. (NYSE:BHVN) stock plummeted on Wednesday, reaching its 52-week low, according to data from Benzinga Pro.
Biohaven shares plunge after US FDA declines to approve brain disorder drug
10:02am, Wednesday, 05'th Nov 2025
Shares of Biohaven fell more than 40% on Wednesday after the U.S. Food and Drug Administration declined to approve its experimental treatment for a rare brain disorder.
FDA Issues Complete Response Letter for Biohaven's VYGLXIA (troriluzole) New Drug Application for Spinocerebellar Ataxia
08:06pm, Tuesday, 04'th Nov 2025
The troriluzole clinical development program encompassed the first industry clinical trials to generate data showing therapeutic potential in patients with spinocerebellar ataxia (SCA), a rare geneti
Biohaven Ltd. (NYSE:BHVN) Given Consensus Recommendation of “Buy” by Analysts
02:33am, Thursday, 23'rd Oct 2025
Shares of Biohaven Ltd. (NYSE: BHVN - Get Free Report) have been given a consensus recommendation of "Buy" by the sixteen analysts that are currently covering the firm, Marketbeat reports. One investm
